GLP-1 agonists are a class of injectable medications that are used for type 2 diabetes and weight management. Some of the agents have also been shown to reduce the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. More recently, these agents have
Anticoagulants are a class of medications that can be used to prevent strokes in patients with nonvalvular atrial fibrillation and for treatment of deep vein thrombosis and pulmonary embolisms. They have been shown to significantly reduce rates of strokes, but patients need to remain compliant with the prescribed regimen for
Antiplatelet medications are a class of medications used by patients who have suffered a heart attack or stroke. They have been shown to significantly reduce rates of heart attacks and strokes, but patients need to remain compliant with the prescribed regimen for proper effectiveness and must take antiplatelets consistently as
